Cervical cancer was the fourth most common cancer among women worldwide in 2022, according to the WHO. Against this backdrop, ...

There's a second vaccine in the works: Cervarix, from GlaxoSmithKline. Cervarix targets two HPV strains, HPV-16 and HPV-18. GSK says it plans to seek FDA approval for Cervarix by the end of the year.

Merck & Co. is leveraging March 4’s International HPV Awareness Day for a marketing campaign in China, lighting up landmark buildings in four megacities in the hopes of reigniting demand amid ...

Cervarix: population analyzed in this table were seronegative to HPV-16 and -18, and PCR DNA negative to 14 high-risk HPV types at study entry. Gardasil: population analyzed in this table were ...